Eceptionist launches self-service COVID-19 vaccine management tool
New tool will help automate and organize COVID-19 vaccine distribution
Global health care software provider Eceptionist has launched a new web-based solution to help private and public organizations manage COVID-19 vaccine distribution.
Dubbed VaxManager, the software as a service (SAAS) solution alleviates the administrative burden of managing COVID tests, flu shots, and other vaccines when they become available.
Telcos offer support amid COVID-19 pandemic Why we’re lucky COVID-19 has come now Salesforce aims to help manage coronavirus vaccine demand State-backed hackers are disrupting COVID-19 vaccine efforts
VaxManager incorporates an organization's COVID guidelines into a test/vaccine request workflow to automatically screen and prioritize vaccine and test requests, the company said.
The mobile-friendly platform also includes a self-registration and self-request portal for patients to ensure quick and easy onboarding. Automated appointment reminders, follow-up notifications, and post-testing and post-vaccine information make the software highly reliable and relevant for patients.
Intelligent vaccine-appointment scheduling, automated triage and high-risk-group screening, and interoperability with third-party clinical systems are other notable features of this tool.
VaxManager service is open to pharmacies, employers, universities, school districts, churches, and any other groups willing to participate in COVID-19 vaccine distribution to patients and citizens.
“VaxManager is a SAAS solution for busy immunization clinics. The platform addresses your existing resource constraints with powerful tools for automated screening and prioritization of high-risk populations to more efficiently distribute the Covid-19 vaccine when it becomes available,” Eceptionist said.
Get the ITPro. daily newsletter
Receive our latest news, industry updates, featured resources and more. Sign up today to receive our FREE report on AI cyber crime & security - newly updated for 2024.